Avobis Bio Receives FDA Fast Track Designation for AVB-114 Implantable Cell Therapy for Crohn’s Perianal Fistulas
Hand-out
Press Releases
Avobis Bio  
February 27, 2025

Avobis Bio Receives FDA Fast Track Designation for AVB-114 Implantable Cell Therapy for Crohn’s Perianal Fistulas

– Only implantable cell therapy for Crohn's perianal fistulas with FDA IND clearance and Fast Track designation –

avatar profile Olean Times Herald

Olean Times Herald


Local & Social